News · 26 weeks61-94%
2026-03-012026-08-23
Mix2490d
- SEC Filings8(33%)
- Insider8(33%)
- Other7(29%)
- Leadership1(4%)
Latest news
25 items- SECSEC Form 15-12G filed by Avanos Medical Inc.15-12G - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form S-8 POS filed by Avanos Medical Inc.S-8 POS - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAvanos Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- INSIDERSVP, Operations Delgado Sigfrido returned $2,765,675 worth of shares to the company (110,627 units at $25.00) and was granted 54,886 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSVP, Chief Financial Officer Galovan Scott Michael returned $5,792,925 worth of shares to the company (231,717 units at $25.00) and was granted 96,121 shares, closing all direct ownership in the company (SEC Form 4) to satisfy tax liability4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERChief Executive Officer Pacitti David returned $19,173,100 worth of shares to the company (766,924 units at $25.00) and was granted 444,730 shares, closing all direct ownership in the company (SEC Form 4) (tax liability)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERDirector Shimer Julie Ann returned $1,252,250 worth of shares to the company (50,090 units at $25.00), closing all direct ownership in the company (SEC Form 4) to cover taxes4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERDirector Oleary Patrick J returned $1,366,000 worth of shares to the company (54,640 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERDirector Franchini Indrani Lall returned $120,425 worth of shares to the company (4,817 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for withholding tax)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERDirector Egbuonu-Davis Lisa returned $345,275 worth of shares to the company (13,811 units at $25.00), closing all direct ownership in the company (SEC Form 4) (for tax liability)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERDirector Blackford Gary returned $2,989,750 worth of shares to the company (119,590 units at $25.00), closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- PRAmerican Industrial Partners Completes Acquisition of Avanos Medical, Inc.NEW YORK and ALPHARETTA, Ga., July 27, 2026 /PRNewswire/ -- American Industrial Partners ("AIP"), an operationally-oriented industrials investor, today announced the closing of the acquisition of Avanos Medical, Inc. ("Avanos" or the "Company") by affiliates of investment funds advised by AIP in a transaction valued at approximately $1.272 billion. Under the terms of the merger agreement, Avanos stockholders will receive $25.00 per share in cash for each share of common stock they own. With the completion of the transaction, the Company's common stock will cease trading on the New York Stock Exchange and Avanos will become a pr
- SECSEC Form 25-NSE filed by Avanos Medical Inc.25-NSE - AVANOS MEDICAL, INC. (0001606498) (Subject)
- SECAvanos Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- PRAvanos Medical, Inc. Stockholders Approve Acquisition by American Industrial PartnersALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today. Based on preliminary voting results, approximately 99.75% of shares voted at the Special Meeting were voted in favor of the transaction, which represented approximately 74.96% of the total outstanding shares of Avanos common stock
- PRKrystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions. V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAvanos Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAvanos Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- PRAvanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending MergerALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger"). The proposed transaction is expected to close no later than July 27, 2026, subject to receipt of Avanos stockholder approval and the satisfaction or waiver of the remaining customary closing conditions. The special meeting of Avanos stockholders to approve the proposed transaction will be held on July 22, 2026,
- SECSEC Form DEFM14A filed by Avanos Medical Inc.DEFM14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form SD filed by Avanos Medical Inc.SD - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form PREM14A filed by Avanos Medical Inc.PREM14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Avanos Medical Inc.SCHEDULE 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)
AVNS FAQ
7 questionsWhat does Avanos Medical Inc. do?
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and...Where does AVNS stock trade?
Avanos Medical Inc. (AVNS) is listed on NYSE.What sector and industry is AVNS in?
Avanos Medical Inc. operates in the Health Care sector, Industrial Specialties industry.When did Avanos Medical Inc. go public?
Avanos Medical Inc. (AVNS) completed its IPO in 2014.What are analysts saying about AVNS?
Avanos Medical Inc. has had 7 recent analyst actions on file. The most recent action was from KeyBanc Capital Markets: Sector Weight on 2023-07-25. Recent price targets range from $3100.00 to $4700.00.What companies are similar to AVNS?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare AVNS side-by-side with any of them on Quantisnow.How can I track AVNS on Quantisnow?
Quantisnow aggregates Avanos Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVNS to receive live email and push alerts on every new disclosure.